These findings suggest that neuron pyroptosis triggered by the NLRP3/caspase-1/GSDMD axis is a crucial factor in neuronal loss in Alzheimer's disease, and MCC950 may be a potential therapeutic agent for AD [228]. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.